Profile
Mr. Organ has held sales, marketing and general management roles in public, private, established and startup companies in the life science, medical device, biotechnology, and pharmaceutical fields.
Most recently, he was Chief Operating Officer of Tanox, Inc., one of Houston's largest and most successful biotech startups.
Former positions of Jeffrey W. Organ
Companies | Position | End |
---|---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Chief Operating Officer | 2007-10-18 |
SimplexityMD, Inc.
SimplexityMD, Inc. Investment ManagersFinance Founded in 2006 by Christopher Wasden and Jeffrey Organ, SimplexityMD is a business incubator and venture capital firm located in Houston, Texas. | Corporate Officer/Principal | 2006-01-01 |
Training of Jeffrey W. Organ
University of Missouri | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Tanox, Inc.
Tanox, Inc. Pharmaceuticals: MajorHealth Technology Tanox, Inc engages in the discovery and development of therapeutic monoclonal antibodies in the areas of asthma, allergy, inflammation, other diseases affecting the human immune system, and infectious diseases. Its product, Xolair (omalizumab), is used for treatment of adults and adolescents with moderate-to-severe persistent asthma | Health Technology |
SimplexityMD, Inc.
SimplexityMD, Inc. Investment ManagersFinance Founded in 2006 by Christopher Wasden and Jeffrey Organ, SimplexityMD is a business incubator and venture capital firm located in Houston, Texas. | Finance |
- Stock Market
- Insiders
- Jeffrey W. Organ